Index - 2020

2020 / 2019 / 2018 / 2017



  • Other
  • Main articleH
  • Attention!LO
  • New
A
ACE inhibitors NSAID 2020 angiotensin II receptor antagonists 2020 coronavirus 2020 corticosteroids 2020 covid-19 2020 pioglitazone 2020 sars-cov-2 2020 Achilles tendon rupture ACP 202052-55 PRP 202052-55 autologous conditioned plasma 202052-55 autologous platelet-rich plasma 202052-55 platelet-rich plasma 202052-55 rotator cuff rupture 202052-55 soft tissue injuries 202052-55 tendinopathy 202052-55 ACP Achilles tendon rupture 202052-55 PRP 202052-55 autologous conditioned plasma 202052-55 autologous platelet-rich plasma 202052-55 platelet-rich plasma 202052-55 rotator cuff rupture 202052-55 soft tissue injuries 202052-55 tendinopathy 202052-55 angiotensin II receptor antagonists ACE inhibitors 2020 NSAID 2020 coronavirus 2020 corticosteroids 2020 covid-19 2020 pioglitazone 2020 sars-cov-2 2020 antithrombotic CYP2C19 20209-14 Cytochrome P450 20209-14 PCI 20209-14 clopidogrel 20209-14 genotyping 20209-14 autologous conditioned plasma ACP 202052-55 Achilles tendon rupture 202052-55 PRP 202052-55 autologous platelet-rich plasma 202052-55 platelet-rich plasma 202052-55 rotator cuff rupture 202052-55 soft tissue injuries 202052-55 tendinopathy 202052-55 autologous platelet-rich plasma ACP 202052-55 Achilles tendon rupture 202052-55 PRP 202052-55 autologous conditioned plasma 202052-55 platelet-rich plasma 202052-55 rotator cuff rupture 202052-55 soft tissue injuries 202052-55 tendinopathy 202052-55
B
bias RCT 20201-8 observational 20201-8 randomised 20201-8 research 20201-8 breast cancer hormone therapy 202022-27 menopausal symptoms 202022-27 breast implant lymphoma 2020
C
clopidogrel CYP2C19 20209-14 Cytochrome P450 20209-14 PCI 20209-14 antithrombotic 20209-14 genotyping 20209-14 coronavirus ACE inhibitors 2020 NSAID 2020 angiotensin II receptor antagonists 2020 corticosteroids 2020 covid-19 2020 pioglitazone 2020 sars-cov-2 2020 corticosteroids ACE inhibitors 2020 NSAID 2020 angiotensin II receptor antagonists 2020 coronavirus 2020 covid-19 2020 pioglitazone 2020 sars-cov-2 2020 covid-19 ACE inhibitors 2020 NSAID 2020 angiotensin II receptor antagonists 2020 coronavirus 2020 corticosteroids 2020 pioglitazone 2020 sars-cov-2 2020 CYP enzymes drug interaction 202015-20 CYP2C19 Cytochrome P450 20209-14 PCI 20209-14 antithrombotic 20209-14 clopidogrel 20209-14 genotyping 20209-14 Cytochrome P450 CYP2C19 20209-14 PCI 20209-14 antithrombotic 20209-14 clopidogrel 20209-14 genotyping 20209-14
D
drug interaction CYP enzymes 202015-20
G
genotyping CYP2C19 20209-14 Cytochrome P450 20209-14 PCI 20209-14 antithrombotic 20209-14 clopidogrel 20209-14
H
hormone therapy breast cancer 202022-27 menopausal symptoms 202022-27
L
lymphoma breast implant 2020
M
melatonine sleep disorders 202041-44 menopausal symptoms breast cancer 202022-27 hormone therapy 202022-27
N
NSAID ACE inhibitors 2020 angiotensin II receptor antagonists 2020 coronavirus 2020 corticosteroids 2020 covid-19 2020 pioglitazone 2020 sars-cov-2 2020
O
observational RCT 20201-8 bias 20201-8 randomised 20201-8 research 20201-8
P
PCI CYP2C19 20209-14 Cytochrome P450 20209-14 antithrombotic 20209-14 clopidogrel 20209-14 genotyping 20209-14 pioglitazone ACE inhibitors 2020 NSAID 2020 angiotensin II receptor antagonists 2020 coronavirus 2020 corticosteroids 2020 covid-19 2020 sars-cov-2 2020 platelet-rich plasma ACP 202052-55 Achilles tendon rupture 202052-55 PRP 202052-55 autologous conditioned plasma 202052-55 autologous platelet-rich plasma 202052-55 rotator cuff rupture 202052-55 soft tissue injuries 202052-55 tendinopathy 202052-55 PRP ACP 202052-55 Achilles tendon rupture 202052-55 autologous conditioned plasma 202052-55 autologous platelet-rich plasma 202052-55 platelet-rich plasma 202052-55 rotator cuff rupture 202052-55 soft tissue injuries 202052-55 tendinopathy 202052-55
R
randomised RCT 20201-8 bias 20201-8 observational 20201-8 research 20201-8 RCT bias 20201-8 observational 20201-8 randomised 20201-8 research 20201-8 research RCT 20201-8 bias 20201-8 observational 20201-8 randomised 20201-8 rotator cuff rupture ACP 202052-55 Achilles tendon rupture 202052-55 PRP 202052-55 autologous conditioned plasma 202052-55 autologous platelet-rich plasma 202052-55 platelet-rich plasma 202052-55 soft tissue injuries 202052-55 tendinopathy 202052-55
S
sars-cov-2 ACE inhibitors 2020 NSAID 2020 angiotensin II receptor antagonists 2020 coronavirus 2020 corticosteroids 2020 covid-19 2020 pioglitazone 2020 sleep disorders melatonine 202041-44 soft tissue injuries ACP 202052-55 Achilles tendon rupture 202052-55 PRP 202052-55 autologous conditioned plasma 202052-55 autologous platelet-rich plasma 202052-55 platelet-rich plasma 202052-55 rotator cuff rupture 202052-55 tendinopathy 202052-55
T
tendinopathy ACP 202052-55 Achilles tendon rupture 202052-55 PRP 202052-55 autologous conditioned plasma 202052-55 autologous platelet-rich plasma 202052-55 platelet-rich plasma 202052-55 rotator cuff rupture 202052-55 soft tissue injuries 202052-55